Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

WDYHV1 Inhibitors

WDYHV1 inhibitors are a class of chemical compounds specifically designed to target and inhibit the activity of the WDYHV1 protein. This protein is a lesser-known but intriguing entity that plays a role in cellular processes through its unique sequence and domain structure. The WDYHV1 protein contains a conserved motif, represented by the sequence WDYHV, which is believed to be involved in protein-protein interactions or enzymatic regulation. Inhibitors targeting WDYHV1 focus on disrupting the function of this motif or other critical regions of the protein, thereby modulating its role in various biochemical pathways. Though the exact biological function of WDYHV1 is still under investigation, it is thought to participate in cellular regulation, possibly through interactions with other proteins or by influencing enzymatic activities that are important for maintaining cellular homeostasis.

The mechanism of action of WDYHV1 inhibitors involves binding to the WDYHV motif or other structurally significant regions of the protein, preventing it from carrying out its normal cellular functions. This inhibition can disrupt key interactions between WDYHV1 and other cellular components, leading to alterations in signaling pathways, protein stability, or enzymatic activities that rely on the presence of WDYHV1. Researchers utilize WDYHV1 inhibitors to explore the precise biological roles of this protein, offering insights into how it contributes to cellular processes such as protein regulation, intracellular signaling, or structural maintenance. By selectively blocking WDYHV1 activity, these inhibitors provide valuable tools for studying the impact of this protein on cellular function and its broader involvement in molecular networks.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$135.00
$1085.00
115
(2)

Bortezomib is a proteasome inhibitor that can indirectly affect NTAN1 by modulating protein degradation pathways, potentially influencing proteins that interact with or are processed by NTAN1.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

MG132, another proteasome inhibitor, could impact the degradation pathways of proteins associated with NTAN1, indirectly influencing its function.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Lactacystin is a proteasome inhibitor that might indirectly affect NTAN1 by altering the degradation of proteins in pathways where NTAN1 is involved.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Epoxomicin, a specific proteasome inhibitor, could potentially affect proteins in pathways related to NTAN1's function.

Thalidomide

50-35-1sc-201445
sc-201445A
100 mg
500 mg
$111.00
$357.00
8
(0)

Thalidomide affects the ubiquitin-proteasome system and might indirectly influence the function of NTAN1 by altering protein ubiquitination pathways.

Lenalidomide

191732-72-6sc-218656
sc-218656A
sc-218656B
10 mg
100 mg
1 g
$50.00
$374.00
$2071.00
18
(1)

Lenalidomide, a derivative of thalidomide, also impacts the ubiquitin-proteasome system, potentially affecting NTAN1 activity.

Pomalidomide

19171-19-8sc-364593
sc-364593A
sc-364593B
sc-364593C
sc-364593D
sc-364593E
5 mg
10 mg
50 mg
100 mg
500 mg
1 g
$100.00
$143.00
$312.00
$468.00
$1248.00
$1997.00
1
(1)

Pomalidomide, related to thalidomide and lenalidomide, may indirectly impact NTAN1 function through its effects on the ubiquitin-proteasome system.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Rapamycin, an mTOR inhibitor, could indirectly affect NTAN1 by modulating signaling pathways that intersect with NTAN1's role in protein processing.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

Wortmannin, a PI3K inhibitor, might influence signaling pathways relevant to NTAN1's function, offering indirect modulation of its activity.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$123.00
$400.00
148
(1)

LY294002, another PI3K inhibitor, may indirectly affect NTAN1 by altering PI3K/Akt signaling pathways.